Characterisation of a novel group B oncolytic adenovirus, ColoAd1

<p>Developing high potent oncolytic virus with multimodal antitumour capabilities is crucial for realizing the full potential of oncolytic virotherapy in cancer treatment. ColoAd1 is a novel replicating chimeric group B adenovirus recently bioselected from a large library of recombinant virus...

Полное описание

Библиографические подробности
Главный автор: Di, Y
Другие авторы: Seymour, L
Формат: Диссертация
Язык:English
Опубликовано: 2011
Предметы: